OncoGenex Pharma (OGXI) Reports Q3 Loss of $0.16
Tweet
Share
E-mailGet Alerts OGXI Hot Sheet
Join SI Premium – FREE
OncoGenex Pharma (NASDAQ: OGXI) reported Q3 EPS of ($0.16), versus ($0.23) reported last year.
For earnings history and earnings-related data on OncoGenex Pharma (OGXI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Four key things investors will watch in Nvidia's earnings next week
- PolyPid Ltd. (PYPD) Tops Q2 EPS by 5c
- TScan Therapeutics, Inc. (TCRX) Tops Q2 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
